Pamela Crowell Brings New Leadership to ISU Research
Since becoming Idaho State University's vice president for research, Pamela Crowell, Ph.D., has emphasized the three "Fs" of research—funding, faculty and facilities.
She also cites the importance of collaboration, both inside and outside of the University.
"Idaho State University has a lot of strengths and a good foundation for research, and great potential for growth, especially interdisciplinary research," Crowell says. "I really see my role here as assisting faculty in reaching their research goals, helping them find the resources they need."
Crowell came to Idaho State University in July from the Indiana University Purdue University Indianapolis (IUPUI) School of Science. She was associate dean for research and graduate education there since 1995.
Besides her administrative background, Crowell is a tenured faculty member in biomedical and pharmaceutical sciences. She brings an extensive background as a research scientist. Her music background—she plays the piano, flute and clarinet—gives her insight as well into the value of creativity in scholarship.
"It is important to measure research in terms of its scholarship and creativity," she says, "and not just in dollars."
Crowell has three goals as vice president for research at Idaho State University:
- increase research, scholarship and creative activity in general;
- increase external funding and build more research infrastructure; and
- increase national visibility of Idaho State University through research, grants and conference presentations.
Dr. Crowell has identified several research focuses for ISU, based on the institution's strengths.
Among them is biomedical research in combination with the Kasiska College of Health Professions, the College of Pharmacy and the departments of biological sciences and chemistry in the College of Arts and Sciences.
Energy research, in conjunction with such entities as the Center for Advanced Energy Studies in Idaho Falls and the Idaho Accelerator Center in Pocatello, is another high priority.
Dr. Crowell received her Ph.D. in biochemistry at the University of Wisconsin-Madison in 1988. She holds a Bachelor of Arts degree in chemistry from Minnesota's Augsburg College.
After completing postdoctoral training in oncology at the University of Wisconsin-Madison and at Eli Lilly & Co., she joined the IUPUI faculty as an assistant professor of biology in 1993.
Her primary research emphasis is in cancer pharmacology. She has received cancer research grants from the National Institutes of Health, private foundations and industry.